Behavioral and Pharmacological Reconsolidation Interference in Misophonia

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

141

Participants

Timeline

Start Date

June 2, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions

Misophonia

Interventions

DRUG

Propranolol Hydrochloride tablet

Single dose of 40 mg propranolol tablet

BEHAVIORAL

Reminder

Reactivation of misophonia trigger memory

BEHAVIORAL

Counterconditioning

Counterconditioning will consist of presentation of misophonia cues paired with monetary rewards.

DRUG

Placebo

Matching placebo tablet

Trial Locations (1)

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT05928689 - Behavioral and Pharmacological Reconsolidation Interference in Misophonia | Biotech Hunter | Biotech Hunter